Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Avanos Medical Still Anticipates FY24 Revenue From Cont. Ops Of $685M - $705M (Est $695.40M), Adjusted EPS From Cont. Ops Of Between $1.30 - $1.45 (Est $1.38)

Author: Benzinga Newsdesk | July 31, 2024 07:11am

Posted In: AVNS